Schuerman, Lode M.

Top Publications

Top Publications Authored or Co-Authored by "Schuerman, Lode M."

• Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

  The Lancet Infectious Diseases, Volume 21, No. 9, Year 2021, Citations 76
• Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

  Human Vaccines and Immunotherapeutics, Volume 15, No. 10, Year 2019, Citations 43
• Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study

  The Lancet Infectious Diseases, Volume 22, No. 5, Year 2022, Citations 42
• Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

  The Lancet Infectious Diseases, Volume 22, No. 9, Year 2022, Citations 40
• Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

  The Lancet Infectious Diseases, Volume 19, No. 8, Year 2019, Citations 37